Walleye Capital’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-388	Closed	-$146K	–	882
2020 Q2	$146K	Sell	388 -1,438	-79%	-$541K	0.03%	473
2020 Q1	$417K	Buy	1,826 +1,698	+1,327%	+$388K	0.09%	185
2019 Q4	$67K	Sell	128 -182	-59%	-$95.3K	﹤0.01%	509
2019 Q3	$134K	Buy	+310	New	+$134K	0.01%	251